Dallas, TX -- (SBWIRE) -- 06/09/2015 -- Browse 111 market data tables, 42 figures spread through 255 pages and in-depth TOC on "NA Isolation and Purification Market"

http://www.marketsandmarkets.com/Market-Reports/nucleic-acid-isolation-purification-market-229978287.html

Early buyers will receive 10% customization on this report.

This report studies the global nucleic acid isolation market over the forecast period of 2013 to 2018. This market is valued at an estimated $2,103.39 million in 2013.

The report segments this market by technology, application, product, end user, and geography. The technology segments included in this report are column–based, magnetic bead-based, reagent-based, and other (anion exchange-based, glass fiber-based) for DNA and RNA isolation and purification. Of these, the column-based technology for DNA isolation and purification commands the largest share of the global market and is also poised to grow at the healthy CAGR between 2013 and 2018. However, magnetic bead-based technology for DNA isolation will grow at highest CAGR during the forecasted period. Use of purified form of DNA in research for various downstream processes is the primary growth driver of this technology segment.

Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=229978287

The application segments included in this report are blood DNA isolation and purification, genomic DNA isolation and purification, micro RNA isolation and purification, mRNA isolation and purification, plasmid DNA isolation and purification, total RNA isolation and purification, and PCR clean up. The plasmid DNA isolation and purification segment commands the largest share of the global market, while micro RNA isolation and purification is poised to grow at the highest CAGR between 2013 and 2018 followed by PCR clean up. The increasing research activities and use of nucleic acid test in molecular diagnostics are driving the growth of this segment.

The end-user segments included in this report are academic research, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, and other end users such as food testing and forensic laboratories. Of these, the academic research end-user segment commands the largest share of the global market, while the hospitals and diagnostic centers end-user segment is poised to grow at the highest CAGR between 2013 and 2018. This growth will be attributed to the increasing applications of nucleic acid tests in molecular diagnostics.

Under the geography segment, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The North American geographic segment is further divided into regional segments of the U.S. and Canada. The European geographic segment is further divided into regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The Asian segment includes regional segments of India, China, Japan, and the Rest of Asia.

You can speak To Research Analyst to know more about Report:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=229978287

The significance of pure nucleic acid for applications in the pharmaceuticals and biotechnological industry has fueled its demand in the research and life science markets. The isolation of nucleic acid in the pure form is needed for drug discovery, molecular diagnostics, and genotypic applications. The technological innovations and advancements; and government initiatives in form of funding for research projects are the factors driving this market. Furthermore, the increasing use of nucleic acid-based tests in diagnosis is expected to drive this market in coming future.

The major players in the nucleic acid isolation market include Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Danaher Corporation (U.S.), Illumina Inc. (U.S.), Life Technologies (U.S.), Promega Corporation (U.S.), Qiagen (Netherlands), Roche Applied Sciences (Germany), and Thermo Fischer Scientific Inc. (U.S.).

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets